Positive Study Results Published for KidneyIntelX™ in Monitoring Patient Response to New Drug Therapy
11 janv. 2022 08h15 HE
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Renalytix (NASDAQ: RNLX) (LSE: RENX) announced the publication of positive study results for KidneyIntelX™ as a risk monitoring tool to...
Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast
10 janv. 2022 07h00 HE
|
Renalytix plc
GULF COAST, Miss. and SALT LAKE CITY, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singing River Health System and Renalytix (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to deploy KidneyIntelX™...
Renalytix Appoints Jean M. Casner as Chief Human Resources Officer
07 janv. 2022 07h00 HE
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M. Casner joined the Company this week on January 3, 2022 as Senior...
Renalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference
05 janv. 2022 07h00 HE
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the Company will be presenting at the upcoming...
American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population
04 janv. 2022 07h00 HE
|
Renalytix plc
ARLINGTON, Va. and SALT LAKE CITY, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The American Diabetes Association® (ADA) and Renalytix (NASDAQ: RNLX) (LSE: RENX) announced today a joint program to improve...
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
07 déc. 2021 07h02 HE
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing...
Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7
02 déc. 2021 07h00 HE
|
Renalytix
NEW YORK and SALT LAKE CITY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will release first quarter fiscal year 2022 financial results on...
Renalytix Convenes Expert Panel at VA Healthcare Summit
10 nov. 2021 07h00 HE
|
Renalytix
NEW YORK and SALT LAKE CITY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- In recognition of National Diabetes Month and concurrent with the launch of KidneyIntelX in the Veterans Health Administration health...
St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York
09 nov. 2021 07h00 HE
|
Renalytix
NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- St. Joseph's Health and Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to implement an advanced clinical care model designed to...
Renalytix Reports Full Year Fiscal 2021 Results
21 oct. 2021 07h00 HE
|
Renalytix
LONDON and SALT LAKE CITY, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical...